In May 2017, ASD acquired an inventory management system specialized for retina practices, according to a Dec. 13 news release from the Justice Department. Through November 2023, ASD offered the system at no cost to customers who entered agreements that required them to purchase a percentage of their specialty drugs from ASD.
ASD required customers who did not enter the agreements to pay a monthly fee for access. Additionally, following its acquisition of the system, ASD discontinued access to the system for non-ASD retina practices that had used the system prior to the acquisition, including those who offered to pay a monthly fee.
Carrollton, Texas-based ASD Specialty Healthcare distributes medical and pharmaceutical products, including ophthalmological injections that treat neovascular age-related macular degeneration.
